The global market for Pharmaceutical Grade Sodium Chloride was estimated at US$664.8 Million in 2023, and is projected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Key Insights:
Market Growth: Understand the significant growth trajectory of the Dialysis End-Use segment, which is expected to reach US$417.5 Million by 2030 with a CAGR of a 6.0%. The Injections End-Use segment is also set to grow at 6.3% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, estimated at $179.3 Million in 2023, and China, forecasted to grow at an impressive 5.1% CAGR to reach $151.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
Detailed Market Analysis: Access a thorough analysis of the Global Pharmaceutical Grade Sodium Chloride Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Pharmaceutical Grade Sodium Chloride Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
How is the Global Pharmaceutical Grade Sodium Chloride Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as Akzo Nobel NV, Dominion Salt Ltd., Hebei Huachen Pharmaceutical Co., Ltd., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 12 Featured):
Akzo Nobel NV
Dominion Salt Ltd.
Hebei Huachen Pharmaceutical Co., Ltd.
K+S France S.A.S.
Morton Salt, Inc.
Salinen Austria Aktiengesellschaft
Sudwestdeutsche Salzwerke AG
Swiss Saltworks
Tianjin Changlu Haijing Group Co., Ltd.
US Salt, LLC.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E)
Global Economic Update
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Increasing Demand for InjecTable Drugs Drives Market Growth
Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity
Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride
Advances in Purification Technologies Enhance Product Quality
Increasing Investment in Healthcare Infrastructure
Development of Biopharmaceuticals and Biosimilars
Expansion of Global Pharmaceutical Manufacturing
Rising Focus on Drug Formulation and Stability
Growth in Clinical Research and Trials
Increasing Applications in Oral Rehydration Solutions
Advances in Drug Delivery Systems Impacting Sodium Chloride Usage
Growth in Emerging Markets Expands Addressable Market Opportunity
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
Table 4: World Recent Past, Current & Future Analysis for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 5: World Historic Review for Dialysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 6: World 16-Year Perspective for Dialysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 7: World Recent Past, Current & Future Analysis for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 8: World Historic Review for Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 9: World 16-Year Perspective for Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 10: World Recent Past, Current & Future Analysis for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 11: World Historic Review for Oral Rehydration Salts (ORS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 12: World 16-Year Perspective for Oral Rehydration Salts (ORS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
Table 16: World Pharmaceutical Grade Sodium Chloride Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 17: USA Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 18: USA Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 19: USA 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
Table 20: Canada Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 21: Canada Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 22: Canada 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 23: Japan Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 24: Japan Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 25: Japan 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 26: China Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: China Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 28: China 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 29: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 30: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 31: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Table 32: Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 33: Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 34: Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 35: France Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 36: France Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 37: France 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 38: Germany Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 39: Germany Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 40: Germany 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
Table 41: Italy Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 42: Italy Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 43: Italy 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 44: UK Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: UK Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 46: UK 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
Table 47: Rest of Europe Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 48: Rest of Europe Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 49: Rest of Europe 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Pharmaceutical Grade Sodium Chloride Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 50: Asia-Pacific Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: Asia-Pacific Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 52: Asia-Pacific 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
Table 53: Rest of World Recent Past, Current & Future Analysis for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 54: Rest of World Historic Review for Pharmaceutical Grade Sodium Chloride by End-Use - Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 55: Rest of World 16-Year Perspective for Pharmaceutical Grade Sodium Chloride by End-Use - Percentage Breakdown of Value Sales for Dialysis, Injections, Oral Rehydration Salts (ORS) and Other End-Uses for the Years 2014, 2024 & 2030
About the Pharmaceutical Grade Sodium Chloride Market
Pharmaceutical Grade Sodium Chloride is a type of pharmaceutical intermediate used in the production of various drugs and medications. It is a white, crystalline powder that is highly soluble in water and is used as a source of chloride ions in pharmaceutical formulations. It is also used as a buffering agent, a preservative, and a stabilizer in pharmaceutical products. It is also used in the production of intravenous solutions, ophthalmic solutions, and other pharmaceutical products.
Pharmaceutical Grade Sodium Chloride is manufactured under strict quality control standards and is subject to rigorous testing to ensure its purity and safety. It is also available in various grades, depending on the application.
Some of the companies in the Pharmaceutical Grade Sodium Chloride market include Merck, Sigma-Aldrich, Lonza, and Spectrum Chemical Manufacturing Corporation. Show Less Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a 1-10 user license, allowing up to ten users have access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.